Back to search
Cutaneous T-Cell Lymphoma, Unspecified
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cutaneous T-Cell Lymphoma, Unspecified trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cutaneous T-Cell Lymphoma, Unspecified trials you may qualify forThis study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).
RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-\[18F\] fluorothymidine (FLT) PET imaging, may help find and diagnose cancer. It may also help doctors pre…
RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering informa…
RATIONALE: Physician-initiated smoking cessation strategies may be effective in getting early-stage cancer patients to quit smoking. PURPOSE: Randomized clinic…
The purpose of this phase I/II trial is to study the side effects and best dose of biological therapy to treat patients at high-risk or with Epstein-Barr virus-…